Volume 27, Issue 4 (December 2023)                   Physiol Pharmacol 2023, 27(4): 357-386 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Okafor I A, Obi N P, Ibeabuchi K C. Herbal treatment options for female fertility disorders: a systematic review of clinical trials. Physiol Pharmacol 2023; 27 (4) : 3
URL: http://ppj.phypha.ir/article-1-1912-en.html
Abstract:   (1405 Views)

Introduction: Herbal medicine has been used as tea, ointment, capsules, syrup, whole herbs, and tablets to treat fertility disorders. The herbs and their treatment use in different localities vary, and the effectiveness of herbal treatment for routine treatment of diseases is still a debated issue to date. This study is a 20-year review of the herbal medicines treatment options for female fertility disorders to provide an updated publication of herbal treatments for female infertility and their associated outcomes, informing further research or translation. Methods: PubMed, Google Scholar, Web of Science, Science Direct, and Cochrane databases were searched for clinical trials using Medical Subject Headings (MeSH) terms and related keywords, which retrieved 336 studies. All cross-sectional studies, reviews, and controlled trials utilizing phytotherapy on study participants without evidence of female infertility were excluded. Only 23 studies published in the English Language between January 2002 and August 2021 were included in the evidence synthesis after article screening. Results: Several herbal treatments in women cause a significant reduction in the symptoms of primary dysmenorrhea, PCOS, endometriosis, luteal phase defect, and vulvovaginal candidiasis, with substantial improvements in pregnancy and live birth rates. The herbal drugs identified from available studies were formulations – tablets or creams - with specified doses and administered orally or intravaginally. Conclusion: Evidence exists that herbal treatments effectively treat female fertility disorders. However, they have not fully established the extent of safety, side effects, and pharmacological mechanisms of the therapeutic effects attributed to these herbal treatments.

Article number: 3
Full-Text [PDF 989 kb]   (292 Downloads)    
Type of Manuscript: Review | Subject: Clinical Physiology/Pharmacology

1. Abu-Rabia A. Herbs as a food and medicine source in Palestine. Asian Pac J Cancer Prev 2005; 6(3):404-07. 2019;17(1):85-89.
2. Adib Rad H, Basirat Z, Bakouei F, et al. Effect of Ginger and Novafen on menstrual pain: A cross-over trial. Taiwan J Obstet Gynecol 2018;57(6):806-09. [DOI:10.1016/j.tjog.2018.10.006]
3. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of can-cer. Biochem Pharmacol 2006; 71(10):1397-1421. [DOI:10.1016/j.bcp.2006.02.009]
4. Aguilar-Guadarrama B, Navarro V, León-Rivera I, Rios MY. Active compounds against tinea pedis dermatophytes from Ageratina pichinchensis var. bustamenta. Nat Prod Res 2009;23(16):1559-1565. [DOI:10.1080/14786410902843301]
5. Ainehchi N, Khaki A, Farshbaf-Khalili A, Hammadeh M, Ouladsahebmadarek E. The effectiveness of herbal mixture supplements with and without clomiphene citrate in comparison to clomiphene citrate on serum antioxidants and glycemic biomarkers in women with polycystic ovary syndrome willing to be pregnant: A randomized clinical trial. Biomolecules 2019;9(6):215. [DOI:10.3390/biom9060215]
6. Akahori A. Studies on the steroidal components of domestic plants-XLIV.: Steroidal sapogenins contained in Japanese Dioscorea sp. Phytochemistry 1965;4(1):97-106. [DOI:10.1016/S0031-9422(00)86151-8]
7. Akour A, Kasabri V, Afifi FU, Bulatova N. The use of medicinal herbs in gynecological and preg-nancy-related disorders by Jordanian women: a review of folkloric practice vs. evidence-based pharmacology. Pharm Biol 2016;54(9):1901-18. [DOI:10.3109/13880209.2015.1113994]
8. Al-Dhubiab BE. Pharmaceutical applications and phytochemical profile of Cinnamomum burmannii. Pharmacogn Rev 2012; 6(12):125-31. [DOI:10.4103/0973-7847.99946]
9. Al-Fartosi KG, Radi H, Al-Rekabi EA. Lipid Profile of Diabetic Male Rats Treated with Phenolic Compounds of Leaves Extracts from Mentha longifolia and Mentha spicata. Int J Pharm Biol 2014;3:26-31.
10. Alibeigi Z, Jafari-Dehkordi E, Kheiri S, Nemati M, Mohammadi-Farsani G, Tansaz M. The Impact of Traditional medicine-based lifestyle and diet on infertility treatment in women undergoing assisted reproduction: A randomized controlled trial. Complement Med Res 2020;27(4):230-41. [DOI:10.1159/000505016]
11. AL-SNAFI AE. Medicinal Value Of Lagerstroemia Speciosa: An Updated Review. Int J Curr Pharm 2019; 18-26. [DOI:10.22159/ijcpr.2019v11i5.35708]
12. Alzweiri M, Sarhan AA, Mansi K, Hudaib M, Aburjai T. Ethnopharmacological survey of medicinal herbs in Jordan, the Northern Badia region. J Ethnopharmacol 2011;137(1):27-35. [DOI:10.1016/j.jep.2011.02.007]
13. Ammar B, Caponi C, Cioni PL, Flamini G, Morelli I. Composition of the essential oil of Ballota undu-lata, B. nigra ssp. foetida and B. saxatilis. FFJ 2003;18:502-04. [DOI:10.1002/ffj.1257]
14. Anderson RA, Broadhurst CL, Polansky MM, et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 2004;52(1):65-70. [DOI:10.1021/jf034916b]
15. Bandaranayake WM. “Quality control, screening, toxicity, and regulation of herbal drugs,” in Mod-ern Phytomedicine. Turning Medicinal Plants into Drugs, eds I. Ahmad, F. Aqil, and M. Owais (Weinheim:Wiley-VCH GmbH & Co. KGaA) 2006; 25-57. [DOI:10.1002/9783527609987.ch2]
16. Barbosa JD, de Oliveira CMC, Duarte MD, Riet-Correa G, Peixoto PV, Tokarnia CH. Poisoning of horses by bamboo, Bambusa vulgaris. JEVS 2006;26(9):393-98. [DOI:10.1016/j.jevs.2006.07.003]
17. Bardaweel SK, Shehadeh M, Suaifan GA, Kilani MV. Complementary and alternative medicine utili-zation by a sample of infertile couples in Jordan for infertility treatment: clinics-based survey. BMC Complement Altern Med 2013;13:35. [DOI:10.1186/1472-6882-13-35]
18. Barnes J, Anderson LA, Phillipson JD. Herbal medicines (3rd edn). Pharmaceutical Press: Lon-don/Chicago, 2007.
19. Basch E, Ulbricht C, Hammerness P, Bevins A, Sollars D. Thyme (Thymus vulgaris L.), thymol. J Herb Pharmacother 2004;4(1):49-67. [DOI:10.1080/J157v04n01_07]
20. Behmanesh E, Delavar MA, Kamalinejad M, Khafri S, Shirafkan H, Mozaffarpur SA. Effect of eryn-go (Eryngium caucasicum Trautv) on primary dysmenorrhea: A randomized, double-blind, placebo-controlled study. Taiwan J Obstet Gynecol 2019;58(2):227-33. [DOI:10.1016/j.tjog.2019.01.011]
21. Benariba N, Djaziri R, Hupkens E, Louchami K, Malaisse WJ, Sener A. Insulinotropic action of Cit-rullus colocynthis seed extracts in rat pancreatic islets. Mol Med Rep 2013;7(1):233-6. [DOI:10.3892/mmr.2012.1151]
22. Benzie IFF, Wachtel-Galor S, eds. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. [DOI:10.1201/b10787]
23. Berek JS, Berek DL, Hengst TC. Lippincott Williams and Wilkins Publishers, fifteenth ed., Berek and Novak’S Gynecology vol. 1, Lippincott Williams and Wilkins Publishers, Philadelphia 2012; 481-3.
24. Bernardi M, Lazzeri L, Perelli F, Reis FM, Petraglia F. Dysmenorrhea and related disorders. F1000Res 2017;6:1645. [DOI:10.12688/f1000research.11682.1]
25. Bhattacharya S, Johnson N, Tijani HA, Hart R, Pandey S, Gibreel AF. Female infertility. BMJ Clin Evid 2010.
26. Biazar G, Nabi BN, Sedighinejad A, Moghadam AD, Farzi F, Atrkarroushan Z, Mirblook F, Mir-mansouri L. Herbal products use during pregnancy in north of Iran. Int J Women’s Health Reprod Sci 2019; 7:134-7. [DOI:10.15296/ijwhr.2019.21]
27. Blazso G, Gabor M, Sibbel R, Rohdewald P. Antiinflammatory and superoxide radical scavenging activities of procyanidins containing extract from the bark of Pinus pinaster Sol. and its fractions. Pharm Pharmacol Lett 1994;3:217-20.
28. Blazso G, Gaspar R., Ga’bor M, Ru¨ve HJ, Rohdewald P. ACE inhibition and hypotensive effect of procyanidinscontaining extract from the bark of Pinus pinaster sol. Pharmaceutical Pharmacology Letters 1996; 6: 8 - 11.
29. Bopp B, Shoupe D. Luteal phase defects. J Reprod Med. 1993;38(5):348-356.
30. Broadhurst CL, Polansky MM, Anderson RA. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 2000;48(3):849-52. [DOI:10.1021/jf9904517]
31. Cai L, Shu Y, Xie H. Clinical and experimental study on the treatment of endometriosis with dan’e mixture.Chinese journal of integrated traditional and Western medicine 1999; 19(3), 159-61.
32. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005;693:4-10. [DOI:10.1159/000088478]
33. Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004;82(3):661-5. [DOI:10.1016/j.fertnstert.2004.01.041]
34. Cassone A. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine pro-spects. BJOG 2015;122(6):785-94. [DOI:10.1111/1471-0528.12994]
35. Chan MF, Mok E, Wong YS, et al. Attitudes of Hong Kong Chinese to traditional Chinese medicine and Western medicine: survey and cluster analysis. Complement Ther Med 2003;11(2):103-09. [DOI:10.1016/S0965-2299(03)00044-X]
36. Chatfield K, Salehi B, Sharifi-Rad J, Afshar L. Applying an Ethical Framework to Herbal Medicine. Evid Based Complement Alternat Med 2018;2018:1903629. [DOI:10.1155/2018/1903629]
37. Chavan P, Joshi K, Patwardhan B. DNA microarrays in herbal drug research. Evid Based Comple-ment Alternat Med 2006;3(4):447-57. [DOI:10.1093/ecam/nel075]
38. Chen JT, Tominaga K, Sato Y, Anzai H, Matsuoka R. Maitake mushroom (Grifola frondosa) extract induces ovulation in patients with polycystic ovary syndrome: a possible monotherapy and a com-bination therapy after failure with first-line clomiphene citrate. J Altern Complement Med 2010; 16(12):1295-99. [DOI:10.1089/acm.2009.0696]
39. Chen XP, Li W, Xiao XF, Zhang LL, Liu CX. Phytochemical and pharmacological studies on Radix Angelica sinensis. Chin J Nat Med 2013;11(6):577-7. [DOI:10.1016/S1875-5364(13)60067-9]
40. Chen ZT, Chu HL, Chyau CC, Chu CC, Duh PD. Protective effects of sweet orange (Citrus sinen-sis) peel and their bioactive compounds on oxidative stress. Food Chem. 2012;135(4):2119-27. [DOI:10.1016/j.foodchem.2012.07.041]
41. Chew CK, Clarke BL. Causes of low peak bone mass in women. Maturitas 2018;111:61-8. [DOI:10.1016/j.maturitas.2017.12.010]
42. Choi HG, Je IG, Kim GJ, et al. Chemical Constituents of the Root of Angelica tenuissima and their Anti-allergic Inflammatory Activity. Nat Prod Commun 2017;12(5):779-80. [DOI:10.1177/1934578X1701200523]
43. Chung YC, Chen HH, Yeh ML. Acupoint stimulation intervention for people with primary dysmen-orrhea: Systematic review and meta-analysis of randomized trials. Complement Ther Med 2012;20(5):353-63. [DOI:10.1016/j.ctim.2012.02.008]
44. Cirlini M, Mena P, Tassotti M, et al. Phenolic and Volatile Composition of a Dry Spearmint (Mentha spicata L.) Extract. Molecules 2016;21(8):1007. [DOI:10.3390/molecules21081007]
45. Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998;13(6):1502-05. [DOI:10.1093/humrep/13.6.1502]
46. Cohen PA, Ernst E. Safety of herbal supplements: a guide for cardiologists. Cardiovasc Ther 2010;28(4):246-53. [DOI:10.1111/j.1755-5922.2010.00193.x]
47. Conover EA. Herbal agents and over-the-counter medications in pregnancy. Best Pract Res Clin Endocrinol Metab 2003;17(2):237-51. [DOI:10.1016/S1521-690X(02)00102-1]
48. Cook CL, Schroeder JA, Yussman MA, Sanfilippo JS. Induction of luteal phase defect with clomi-phene citrate. Am J Obstet Gynecol 1984;149(6):613-16. [DOI:10.1016/0002-9378(84)90244-8]
49. Cook JD. Reproductive Endocrinology in Infertility.laboratorymedicine 2004;9(35), 1-5. [DOI:10.1309/J9BBA3949UWUH0VJ]
50. Cuzzolin L, Francini-Pesenti F, Verlato G, Joppi M, Baldelli P, Benoni G. Use of herbal products among 392 Italian pregnant women: focus on pregnancy outcome. Pharmacoepidemiol Drug Saf 2010;19(11):1151-58. [DOI:10.1002/pds.2040]
51. D’Andrea G. Pycnogenol: a blend of procyanidins with multifaceted therapeutic applications?. Fitoterapia. 2010; 81(7):724-36. [DOI:10.1016/j.fitote.2010.06.011]
52. D’Arcy PF. Adverse reactions and interactions with herbal medicines. Part 2Drug interactions. Ad-verse Drug React Toxicol Rev 1993;12(3):147-62.
53. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 2006;108(2):428-41. [DOI:10.1097/01.AOG.0000230214.26638.0c]
54. Dervendzi V. Contemporary treatment with medicinal plants. Skopje: Tabernakul, 1992 p. 5-43.
55. Deshpande SS. Handbook of food toxicology. New York: Marcel Dekker, 2002. [DOI:10.1201/9780203908969]
56. Ebrahimzadeh MA, Nabavi SF, Nabavi SM. Pourmorad F. Nitric oxide radical scavenging potential of some Elburz medicinal plants. African Journal of Biotechnology 2010; 9 (32) :5212-17
57. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280(18):1569-75. [DOI:10.1001/jama.280.18.1569]
58. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014;4:177. [DOI:10.3389/fphar.2013.00177]
59. Elstner EF, Kleber E. Radical scavenger properties of leucocyanidine. In: Das NP, editor. Flavo-noids in biology and medicine III: current issues in flavonoids research. Singapore: Natl Univ of Singapore Press 1990; 227-35.
60. Eslami S, Ebrahimzadeh M, Moghaddam HA, Nabavi S, Jafari N, Nabavi S. Renoprotective effect of eryngium caucasicum in Gentamicin-induced nephrotoxic mice.Archives of Biological Sciences 2011;63 (1) :157-60. [DOI:10.2298/ABS1101157E]
61. Esteves SC, Humaidan P, Roque M, Agarwal A. Female infertility and assisted reproductive tech-nology. Panminerva Med 2019;61(1):1-2. [DOI:10.23736/S0031-0808.18.03553-X]
62. Etuk SJ. Reproductive health: global infertility trend. Niger J Physiol Sci 2009;24(2):85-90. [DOI:10.4314/njps.v24i2.52920]
63. Fairbairn JW. The distribution of anthraquinone glycosides in Cassia senna L. Phytochemistry 1987;6(9):1203-07. [DOI:10.1016/S0031-9422(00)86082-3]
64. Falodun A. Herbal Medicine in Africa-Distribution, Standardization and Prospects. Research Jour-nal of Phytochemistry 2010; 4: 154-61. [DOI:10.3923/rjphyto.2010.154.161]
65. Falsetto, S. The Practice of Plant Medicine: Herbal medicine, homeopathy, naturopathy and aroma-therapy. 2009.
66. Farhan H, Rammal H, Hijazi A, et al. Chemical composition and antioxidant activity of a Lebanese plant Euphorbia macroclada schyzoceras. Asian Pac J Trop Biomed 2013;3(7):542-8. [DOI:10.1016/S2221-1691(13)60110-0]
67. Firenzuoli F, Gori L. Herbal medicine today: clinical and research issues. Evid Based Complement Alternat Med 2007; 4 (Suppl 1):37-40. [DOI:10.1093/ecam/nem096]
68. Florido-Lopez JF, Gonzalez-Delgado P, Saenz de San Pedro B, Perez-Miranda C, Arias de Saa-vedra JM, Marin-Pozo JF. Allergy to natural honeys and camomile tea. Int Arch Allergy Immunol 1995;108(2):170-4. [DOI:10.1159/000237135]
69. Flower A, Lewith GT, Little P. A feasibility study exploring the role of Chinese herbal medicine in the treatment of endometriosis. J Altern Complement Med 2011;17(8):691-9. [DOI:10.1089/acm.2010.0073]
70. Ghosh P, Markin RS, Sorrell MF. Coumarin-induced hepatic necrosis. Am J Gastroenterol 1997;92(2):348-9.
71. Ginger, NCCIH Herbs at a Glance. US NCCIH. 1 September 2016. Retrieved 10 September 2021.
72. Goto H, Satoh N, Hayashi Y, et al. A chinese herbal medicine, tokishakuyakusan, reduces the worsening of impairments and independence after stroke: a 1-year randomized, controlled trial. Evid Based Complement Alternat Med 2011;194046. [DOI:10.1093/ecam/nep026]
73. Grant KL, Lutz RB. Ginger. Am J Health Syst Pharm. 2000;57(10):945-47. [DOI:10.1093/ajhp/57.10.945]
74. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Anti-Müllerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003;211(1-2):85-90. [DOI:10.1016/j.mce.2003.09.024]
75. Guo J, Li D, Liu C, Ji X, Li R, Du X. Effects of Chinese herbs combined with in vitro fertilization and embryo transplantation on infertility: a clinical randomized controlled trial. J Tradit Chin Med 2014;34(3):267-73. [DOI:10.1016/S0254-6272(14)60089-3]
76. Hagino N. An overview of Kampo medicine: Toki-Shakuyaku-San (TJ-p23). Phytotherapy Research 1993;7(6):391-94. [DOI:10.1002/ptr.2650070602]
77. Haj-Husein I, Tukan S, Alkazaleh F. The effect of marjoram (Origanum majorana) tea on the hor-monal profile of women with polycystic ovary syndrome: a randomised controlled pilot study. J Hum Nutr Diet 2016;29(1):105-111. [DOI:10.1111/jhn.12290]
78. Hajimonfarednejad M, Nimrouzi M, Heydari M, Zarshenas MM, Raee MJ, Jahromi BN. Insulin re-sistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial. Phytother Res 2018;32(2):276-83. [DOI:10.1002/ptr.5970]
79. Harrison RA, Holt D, Pattison DJ, Elton PJ. Who and how many people are taking herbal supple-ments? A survey of 21,923 adults. Int J Vitam Nutr Res 2004;74(3):183-6. [DOI:10.1024/0300-9831.74.3.183]
80. Hart RJ. Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics. Physiol Rev 2016;96(3):873-909. [DOI:10.1152/physrev.00023.2015]
81. Hartmann T. From waste products to ecochemicals: fifty years research of plant secondary metab-olism. Phytochemistry 2007;68(22-24):2831-46. [DOI:10.1016/j.phytochem.2007.09.017]
82. Hasan HA, Rasheed Raauf AM, Abd Razik BM, Rasool Hassan BA. Pharmaceut Chemical Compo-sition and Antimicrobial Activity of the Crude ExtractsIsolated from Zingiber Officinale by Different Solvents. Pharmaceute AnalyticaActa 2012;3:184.
83. Higaki S, Toyomoto T, Morohashi M. Seijo-bofu-to, Jumi-haidoku-to and Toki-shakuyaku-san sup-press rashes and incidental symptoms in acne patients. Drugs Exp Clin Res 2002;28(5):193-6.
84. Hill MS. Understanding Environmental Pollution. 3rd ed. Cambridge: Cambridge University Press, 1997,p 316.
85. Hosseini S, Jeongmin L, Sepulveda RT, Rohdewald P, Watson RR. A randomized, double-blind, placebocontrolled, prospective, 16-week crossover study to determine the role of PycnogenolR in modifying blood pressure in mildly hypertensive patients. Nutrition Research 2001;21:1251 - 60. [DOI:10.1016/S0271-5317(01)00342-6]
86. Hosseinzadeh S, Jafarikukhdan A, Hosseini A, Armand R. The Application of Medicinal Plants in Traditional and Modern Medicine: A Review of Thymus vulgaris. International Journal of Clinical Medicine 2015;6:635-42. [DOI:10.4236/ijcm.2015.69084]
87. Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technolo-gies and global movements in the 21st century. Hum Reprod Update 2015;21(4):411-26. [DOI:10.1093/humupd/dmv016]
88. Jaafarpour M, Hatefi M, Khani A, Khajavikhan J. Comparative effect of cinnamon and Ibuprofen for treatment of primary dysmenorrhea: a randomized double-blind clinical trial. J Clin Diagn Res 2015;9(4). [DOI:10.7860/JCDR/2015/12084.5783]
89. Jahangirifar M, Taebi M, Dolatian M. The effect of Cinnamon on primary dysmenorrhea: A random-ized, double-blind clinical trial. Complement Ther Clin Pract 2018;33:56-60. [DOI:10.1016/j.ctcp.2018.08.001]
90. Jung YD, Ellis LM. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol 2001;82(6):309-16. [DOI:10.1046/j.1365-2613.2001.00205.x]
91. Kang JL, Xia W, He QY. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi Chin J Integr Med 2001;21(6), 416-18.
92. Kang TH, Choi SZ, Lee TH, Son MW, Kim SY. Characteristics of antidiabetic effect of Dioscorea rhizome-Hypoglycemic Effect-1. Korean J Food &Nutr 2008;21(4):425-29.
93. Kang TH, Choi SZ, Lee TH, Son MW, Park JH, Kim SY. Characteristics of Antidiabetic Effect of Dioscorea rhizome (2) -Prevention of Diabetic Neuropathy by NGF Induction. Korean J Food & Nutr 2008;21(4):430-35.
94. Kashani L, Akhondzadeh S. Female Infertility and Herbal Medicine. Journal of Medicinal Plants 2017;16:61.
95. Kaul PN, Joshi BS. Alternative medicine: herbal drugs and their critical appraisal--part II. Prog Drug Res 2001;57:1-75. [DOI:10.1007/978-3-0348-8308-5_1]
96. Kelly K. History of medicine. New York: Facts on file,2009, p. 29-50.
97. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003;26(12):3215-18. [DOI:10.2337/diacare.26.12.3215]
98. Khoshbakht K, Hammer K, Pistrick K. Eryngium caucasicum Trautv. cultivated as a vegetable in the Elburz Mountains (Northern Iran). Genetic Resources and Crop Evolution, 2006;54(2), 445-448. [DOI:10.1007/s10722-006-9121-5]
99. Khushboo PS, Jadhav VM, Kadam VJ, Sathe NS. Psoralea corylifolia Linn.-”Kushtanashini”. Phar-macogn Rev 2010;4(7):69-76. [DOI:10.4103/0973-7847.65331]
100. Kim MJ, Sung H, Hong KE. Effects of Dioscoreae Rhizoma (SanYak) on Peripheral Neuropathy and its Safety. J Pharmacopuncture 2013;16(3):7-10. [DOI:10.3831/KPI.2013.16.015]
101. Kohama T, Herai K, Inoue M. Effect of French maritime pine bark extract on endometriosis as compared with leuprorelin acetate. J Reprod Med 2007;52(8):703-08.
102. Kohama T, Suzuki N, Ohno S, Inoue M. Analgesic efficacy of French maritime pine bark extract in dysmenorrhea: an open clinical trial. J Reprod Med 2004;49(10):828-32.
103. Kooti W, Moradi M, Peyro K, et al. The effect of celery (Apium graveolens L.) on fertility: A sys-tematic review. J Complement Integr Med 2017;15(2). [DOI:10.1515/jcim-2016-0141]
104. Kort DH, Lobo RA. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. Am J Obstet Gynecol 2014;211(5):487.e1-487.e4876. [DOI:10.1016/j.ajog.2014.05.009]
105. Kotani N, Oyama T, Sakai I, et al. Analgesic effect of a herbal medicine for treatment of primary dysmenorrheaa double-blind study. Am J Chin Med 1997;25(2):205-12. [DOI:10.1142/S0192415X9700024X]
106. Laschke MW, Schwender C, Scheuer C, Vollmar B, Menger MD. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod 2008;23(10):2308-18. [DOI:10.1093/humrep/den245]
107. Lee KS, Park JH, Jeong JB, Hong SC, Park KH, Jeong HY. Protective effect of the extracts from Dioscorea japonica Thunberg against H2O2 induced oxidative DNA damage via antioxidant activity. Korean J Plant Resour 2009;5:155.
108. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 dia-betes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, con-trolled study in 254 affected women. J Clin Endocrinol Metab 1999;84(1):165-9. [DOI:10.1210/jcem.84.1.5393]
109. Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science 2009;325(5937):161-5. [DOI:10.1126/science.1168243]
110. Li S, Lo CY, Ho CT. Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel. J Agric Food Chem 2006;54(12):4176-4185. [DOI:10.1021/jf060234n]
111. Lin CF, Yu-Ling H, Mei-Yin C, Shuenn-Jyi S, Chien-Chin C. Analysis of Bakuchiol, Psoralen and Angelicin in crude drugs and commercial concentrated products of Fructus Psoraleae. J Food Drug Anal 2007;15:433-7. [DOI:10.38212/2224-6614.2399]
112. Lindsay TJ, Vitrikas KR. Evaluation and treatment of infertility [published correction appears in Am Fam Physician. 2015 Sep 15;92 (6):437]. Am Fam Physician 2015;91(5):308-14.
113. Liu X, Wei J, Tan F, Zhou S, Würthwein G, Rohdewald P. Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sci 2004;74(7):855-62. [DOI:10.1016/j.lfs.2003.07.037]
114. Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 2003;(3):CD003053. [DOI:10.1002/14651858.CD003053]
115. Loya AM, González-Stuart A, Rivera JO. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study. Drugs Aging 2009;26(5):423-36. [DOI:10.2165/00002512-200926050-00006]
116. Luciano AA, Lanzone A, Goverde AJ. Management of female infertility from hormonal causes. Int J Gynaecol Obstet 2013;123. [DOI:10.1016/j.ijgo.2013.09.007]
117. Lungarini S, Aureli F, Coni E. Coumarin and cinnamaldehyde in cinnamon marketed in Italy: a natu-ral chemical hazard?. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008;25(11):1297-1305. [DOI:10.1080/02652030802105274]
118. Luu TH, Uy-Kroh MJ. New Developments in Surgery for Endometriosis and Pelvic Pain. Clin Ob-stet Gynecol 2017;60(2):245-51. [DOI:10.1097/GRF.0000000000000282]
119. Machado DE, Abrao MS, Berardo PT, Takiya CM, Nasciutti LE. Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly high-er in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 2008;90(1):148-55. [DOI:10.1016/j.fertnstert.2007.05.076]
120. Mang B, Wolters M, Schmitt B, et al. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 2006;36(5):340-4. [DOI:10.1111/j.1365-2362.2006.01629.x]
121. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2015;2015(7):CD001751. [DOI:10.1002/14651858.CD001751.pub3]
122. Márki G, Bokor A, Rigó J, Rigó A. Physical pain and emotion regulation as the main predictive fac-tors of health-related quality of life in women living with endometriosis. Hum Reprod 2017;32(7):1432-38. [DOI:10.1093/humrep/dex091]
123. Marzouk TM, El-Nemer AM, Baraka HN. The effect of aromatherapy abdominal massage on allevi-ating menstrual pain in nursing students: a prospective randomized cross-over study. Evid Based Complement Alternat Med 2013;742421. [DOI:10.1155/2013/742421]
124. Matalliotakis IM, Goumenou AG, Koumantakis GE, et al. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Im-munopharmacol 2003;3(1):81-9. [DOI:10.1016/S1567-5769(02)00216-3]
125. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Up-date 2000;6(1):45-55. [DOI:10.1093/humupd/6.1.45]
126. Medicinal Plants In the Republic of Korea. Natural Products research institute (Seoul National Uni-versity). p. 3.
127. Mensah LKM, Komlaga G, Forkuo DA, Firempong C, Anning AK, Dickson RA. Toxicity and Safety Implications of Herbal Medicines Used in Africa. Herbal Medicine 2019.
128. Miller P, Soules M. Luteal Phase Deficiency: Pathophysiology, Diagnosis, and Treatment. Glob. libr. women’s med 2009; 1756-2228. [DOI:10.3843/GLOWM.10327]
129. Mirabi P, Alamolhoda SH, Esmaeilzadeh S, Mojab F. Effect of medicinal herbs on primary dysmen-orrhoea- a systematic review. Iran J Pharm Res 2014;13(3):757-67.
130. Mitwally MF, Casper RF. Aromatase inhibitors in ovulation induction. Semin Reprod Med 2004;22(1):61-78. [DOI:10.1055/s-2004-823028]
131. Miyoshi N, Nakamura Y, Ueda Y, et al. Dietary ginger constituents, galanals A and B, are potent apoptosis inducers in Human T lymphoma Jurkat cells. Cancer Lett 2003;199(2):113-19. [DOI:10.1016/S0304-3835(03)00381-1]
132. Modarres M, Mirmohhamad AM, Oshrieh Z, Mehran A. Comparison of the effect of mefenamic acid and matricaria camomilla capsules on primary dysmenorrheal. 2011.
133. Moghaddam AH, Javaheri M, Nabavi SF, Mahdavi MR, Nabavi SM, Ebrahimzadeh MA. Protective role of Pleurotus porrigens (Angel’s wings) against gentamicin-induced nephrotoxicty in mice. Eur Rev Med Pharmacol Sci 2010;14(12):1011-14.
134. Muanya C. Poor funding, weak regulation cripple efforts to develop traditional medicine. The Guardian. https://guardian.ng/features/poor-funding-weak-regulation-cripple-efforts-to-develop-traditional-medicine/2019, August 31.
135. Nachtigall RD. International disparities in access to infertility services. Fertil Steril. 2006;85(4):871-75. [DOI:10.1016/j.fertnstert.2005.08.066]
136. Nasri H, Shirzad H. Toxicity and safety of medicinal plants. Journal of Herb med Pharmacology 2013; 2(2):21-2.
137. National Center for Biotechnology Information. PubChem compound Summary for CID 65064, Ep-igallocatechin gallate. 2021. Retrieved September 9, 2021.
138. National Collaborating Centre for Women’s and Children’s Health (UK). Fertility: Assessment and Treatment for People with Fertility Problems; National Institute for Health and Clinical Excellence (NICE). 2013;1-63. (Clinical guideline no. 156).
139. Ndhlovu DF. Funding woes afflict African herbal therapy institute. Nature 2010. [DOI:10.1038/news.2010.602]
140. Owolabi MS, Padilla-Camberos E, Ogundajo AL, et al. Insecticidal activity and chemical composition of the Morinda lucida essential oil against pulse beetle Callosobruchus maculatus. Scientific-WorldJournal 2014;784613. [DOI:10.1155/2014/784613]
141. Ozgoli G, Goli M, Moattar F. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. J Altern Complement Med 2009;15(2):129-32. [DOI:10.1089/acm.2008.0311]
142. Pang B, Pang Q, Pang H, Song G. Clinical effect of Jiutengzhuyu tablets on promoting blood cir-culation in women with oviducal obstruction. J Tradit Chin Med 2012;32(4):549-53. [DOI:10.1016/S0254-6272(13)60069-2]
143. Park JJ, Kang M, Shin S, et al. Unexplained infertility treated with acupuncture and herbal medicine in Korea [published correction appears in J Altern Complement Med. J Altern Complement Med 2010;16(2):193-8. [DOI:10.1089/acm.2008.0600]
144. Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira MBPP. Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review. Phytother Res 2018;32(12):2323-39. [DOI:10.1002/ptr.6178]
145. Patel JC, Patel PB, Acharya H, Nakum K, Tripathi CB. Efficacy and safety of lornoxicam vs ibu-profen in primary dysmenorrhea: a randomized, double-blind, double dummy, active-controlled, cross over study. Eur J Obstet Gynecol Reprod Biol 2015;188:118-23. [DOI:10.1016/j.ejogrb.2015.03.005]
146. Patil SM, Ramu R, Shirahatti PS, Shivamallu C, Amachawadi RG. A systematic review on eth-nopharmacology, phytochemistry and pharmacological aspects of Thymus vulgaris Linn. Heliyon 2021;7(5):07054. [DOI:10.1016/j.heliyon.2021.e07054]
147. Petrovska BB. Historical review of medicinal plants’ usage. Pharmacogn Rev 2012;6(11):1-5. [DOI:10.4103/0973-7847.95849]
148. Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91(3):941-5. [DOI:10.1210/jc.2005-2076]
149. Pongrojpaw D, Somprasit C, Chanthasenanont A. A randomized comparison of ginger and dimen-hydrinate in the treatment of nausea and vomiting in pregnancy. J Med Assoc Thai 2007;90(9):1703-09.
150. Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med 2013;13(1):7-12. [DOI:10.7861/clinmedicine.13-1-7]
151. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300(24):2867-78. [DOI:10.1001/jama.2008.892]
152. Qiao CF, Han QB, Mo SF, et al. Psoralenoside and isopsoralenoside, two new benzofuran glyco-sides from Psoralea corylifolia. Chem Pharm Bull 2006;54(5):714-16. [DOI:10.1248/cpb.54.714]
153. Rahmani AH, Shabrmi FM, Aly SM. Active ingredients of ginger as potential candidates in the pre-vention and treatment of diseases via modulation of biological activities. Int J Physiol Pathophysiol Pharmacol 2014;6(2):125-36.
154. Rammal H, Farhan H, Jamaleddine N, El Mestrah M, Nasser M, Hijazi A. Effects of altitude on the chemical composition and on some biological properties of Lebanese Eryngium creticum L. J Chem Pharm Res 2015;7(6):887-93.
155. Ranasinghe P, Jayawardana R, Galappaththy P, Constantine GR, de Vas Gunawardana N, Katu-landa P. Efficacy and safety of ‘true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med 2012;29(12):1480-92. [DOI:10.1111/j.1464-5491.2012.03718.x]
156. Ranasinghe P, Pigera S, Premakumara GA, Galappaththy P, Constantine GR, Katulanda P. Medici-nal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Comple-ment Altern Med 2013;13:275. [DOI:10.1186/1472-6882-13-275]
157. Ríos JL. Chemical constituents and pharmacological properties of Poria cocos. Planta Med 2011;77(7):681-91. [DOI:10.1055/s-0030-1270823]
158. Rocha AL, Reis FM, Petraglia F. New trends for the medical treatment of endometriosis. Expert Opin Investig Drugs 2012;21(7):905-19. [DOI:10.1517/13543784.2012.683783]
159. Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 2002;40(4):158-68. [DOI:10.5414/CPP40158]
160. Romero-Cerecero O, Islas-Garduño AL, Zamilpa A, Tortoriello J. Effectiveness of ageratina pich-inchensis extract in patients with vulvovaginal candidiasis. A randomized, double-blind, and con-trolled pilot study. Phytother Res 2017;31(6):885-90. [DOI:10.1002/ptr.5802]
161. Romero-Cerecero O, Zamilpa A, Díaz-García ER, Tortoriello J. Pharmacological effect of Ageratina pichinchensis on wound healing in diabetic rats and genotoxicity evaluation. J Ethnopharmacol 2014;156:222-7. [DOI:10.1016/j.jep.2014.09.002]
162. Romero-Cerecero O, Zamilpa-Álvarez A, Jiménez-Ferrer E, Tortoriello J. Exploratory study on the effectiveness of a standardized extract from Ageratina pichinchensis in patients with chronic ve-nous leg ulcers. Planta Med 2012;78(4):304-10. [DOI:10.1055/s-0031-1280448]
163. Ruan B, Kong LY, Takaya Y, Niwa M. Studies on the chemical constituents of Psoralea corylifolia L. J Asian Nat Prod Res 2007;9(1):41-4. [DOI:10.1080/10286020500289618]
164. Rutstein SO, Shah IH. Infecundity, infertility, and childlessness in developing countries. DHS Comparative Reports No. 9. World Health Organization, Geneva, Switzerland. 2004.
165. Ryan JL, Heckler CE, Roscoe JA, et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer 2012;20(7):1479-89. [DOI:10.1007/s00520-011-1236-3]
166. Sah P, Agrawal D, Garg SP. Isolation and identification of furocoumarins from the seeds of Psora-lea corylifolia L. Indian J Pharma Sci 2006; 68:768-71. [DOI:10.4103/0250-474X.31012]
167. Sahoo N, Manchikanti P, Dey S. Herbal drugs: standards and regulation. Fitoterapia 2010;81(6):462-71. [DOI:10.1016/j.fitote.2010.02.001]
168. Said O, Khalil K, Fulder S, Azaizeh H. Ethnopharmacological survey of medicinal herbs in Israel, the Golan Heights and the West Bank region. J Ethnopharmacol 2002;83(3):251-65. [DOI:10.1016/S0378-8741(02)00253-2]
169. Sakamoto S, Hagino N, Toriizuka K. Effect of Toki-Shakuyaku-San (TJ-23) on the activity of cho-line acetyltransferase in the brain of menopausal rats. Phytotherapy Research 1994; 8(4):208-11. [DOI:10.1002/ptr.2650080404]
170. Sakamoto S, Kudo H, Suzuki S, et al. Pharmacotherapeutic effects of toki-shakuyaku-san on leu-korrhagia in young women. Am J Chin Med 1996;24(2):165-168. [DOI:10.1142/S0192415X96000219]
171. Salmalian H, Saghebi R, Moghadamnia AA, et al. Comparative effect of thymus vulgaris and ibu-profen on primary dysmenorrhea: A triple-blind clinical study. Caspian J Intern Med 2014;5(2):82-8.
172. Shan B, Cai YZ, Brooks JD, Corke H. Antibacterial properties and major bioactive components of cinnamon stick (Cinnamomum burmannii): activity against foodborne pathogenic bacteria. J Agric Food Chem 2007;55(14):5484-90. [DOI:10.1021/jf070424d]
173. Shirvani MA, Motahari-Tabari N, Alipour A. The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial. Arch Gynecol Obstet 2015;291(6):1277-81. [DOI:10.1007/s00404-014-3548-2]
174. Sieniawska E, Baj T. Tannins. Pharmacognosy. 2017; 199-232. [DOI:10.1016/B978-0-12-802104-0.00010-X]
175. Susumu MP. “Cinnamomum burmannii” (PDF). Weeds of Hawaiʻi’s pastures and natural areas: an identification and management guide. University of Hawaiʻi at Mānoa: College of Tropical Agricul-ture and Human Resources. 2003.
176. Szczuko M, Skowronek M, Zapałowska-Chwyć M, Starczewski A. Quantitative assessment of nutri-tion in patients with polycystic ovary syndrome (PCOS). Rocz Panstw Zakl Hig 2016;67(4):419-26.
177. Tabanca N, Gao Z, Demirci B, et al. Molecular and phytochemical investigation of Angelica dahuri-ca and Angelica pubescentis essential oils and their biological activity against Aedes aegypti, Stephanitis pyrioides, and Colletotrichum species. J Agric Food Chem 2014;62(35):8848-57. [DOI:10.1021/jf5024752]
178. Tahoonian-Golkhatmy F, Abedian Z, Emami SA, Esmaily H. Comparison of Rosemary and Mefenamic Acid Capsules on Menstrual Bleeding and Primary Dysmenorrhea: A Clinical Trial. Iran J Nurs Midwifery Res 2019;24(4):301-05.
179. Tamrakar SR, Bastakoti R. Determinants of Infertility in Couples. J Nepal Health Res Counc. 2019 Apr 28;17(1):85-89. [DOI:10.33314/jnhrc.1827]
180. Tanaka T. A novel anti-dysmenorrhea therapy with cyclic administration of two Japanese herbal medicines. Clin Exp Obstet Gynecol 2003;30(2-3):95-8.
181. Tanbo T, Mellembakken J, Bjercke S, Ring E, Åbyholm T, Fedorcsak P. Ovulation induction in pol-ycystic ovary syndrome. Acta Obstet Gynecol Scand 2018;97(10):1162-67. [DOI:10.1111/aogs.13395]
182. Tandrasasmita OM, Wulan DD, Nailufar F, Sinambela J, Tjandrawinata RR. Glucose-lowering effect of DLBS3233 is mediated through phosphorylation of tyrosine and upregulation of PPARγ and GLUT4 expression. Int J Gen Med 2011;4:345-57. [DOI:10.2147/IJGM.S16517]
183. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci 2002;955:89-406. [DOI:10.1111/j.1749-6632.2002.tb02769.x]
184. Taylor RN, Yu J, Torres PB, et al. Mechanistic and therapeutic implications of angiogenesis in en-dometriosis. Reprod Sci 2009;16(2):140-6. [DOI:10.1177/1933719108324893]
185. Tjandrawinata RR, Suastika K. Nofiamy D. DLBS3233 extract, a novel insulin sensitizer with negli-gible risk of hypoglycemia: A phase-I study. Int J Diabetes Metab 2012;21:13-20. [DOI:10.1159/000497721]
186. Tjokroprawiro A, Murtiwi S, Tjandrawinata RR. DLBS3233, a combined bioactive fraction of Cin-namomum burmanii and Lagerstroemia speciosa, in type-2 diabetes mellitus patients inadequately controlled by metformin and other oral antidiabetic agents. J Complement Integr Med 2016;13(4):413-20. [DOI:10.1515/jcim-2016-0031]
187. Tomoda M, Tanaka M., Kondo N. Water-soluble constituents of Rehmanniae Radix. II. On the Constituents of roots of Rehmannia glutinosa var. purpurea. Chem Pharm Bull 1971;19: 2411-16. [DOI:10.1248/cpb.19.2411]
188. Tsai ML, Lin CC, Lin WC, Yang CH. Antimicrobial, antioxidant, and anti-inflammatory activities of essential oils from five selected herbs. Biosci Biotechnol Biochem 2011;75(10):1977-83. [DOI:10.1271/bbb.110377]
189. Urman B, Yakin K. Ovulatory disorders and infertility. J Reprod Med 2006;51(4):267-82.
190. Usta J, Kreydiyyeh S, Barnabe P, Bou-Moughlabay Y, Nakkash-Chmaisse H. Comparative study on the effect of cinnamon and clove extracts and their main components on different types of ATPases. Hum Exp Toxicol 2003;22(7):355-62.
191. Usuki S, Higa TN, Soreya K. The improvement of luteal insufficiency in fecund women by tokisha-kuyakusan treatment. Am J Chin Med 2002;30(2-3):327-38. [DOI:10.1142/S0192415X02000247]
192. Usuki S. Effects of hachimijiogan, tokishakuyakusan and keishibukuryogan on the corpus luteum function and weights of various organs in vivo. Am J Chin Med 1987;15(3-4):99-108. [DOI:10.1142/S0192415X87000138]
193. Vági E, Rapavi E, Hadolin M, et al. Phenolic and triterpenoid antioxidants from Origanum majorana L. herb and extracts obtained with different solvents. J Agric Food Chem 2005;53(1):17-21. [DOI:10.1021/jf048777p]
194. van Breemen RB, Tao Y, Li W. Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale). Fitot-erapia 2011;82(1):38-43. [DOI:10.1016/j.fitote.2010.09.004]
195. Vigo E, Cepeda A, Gualillo O, Perez-Fernandez R. In-vitro anti-inflammatory effect of Eucalyptus globulus and Thymus vulgaris: nitric oxide inhibition in J774A.1 murine macrophages. J Pharm Pharmacol 2004;56(2):257-63. [DOI:10.1211/0022357022665]
196. Virgili F, Kobuchi H, Packer L. Procyanidins extracted from Pinus maritima (Pycnogenol): scaven-gers of free radical species and modulators of nitrogen monoxide metabolism in activated murine RAW 264.7 macrophages. Free Radic Biol Med 1998;24(7-8):1120-29. [DOI:10.1016/S0891-5849(97)00430-9]
197. Wachtel-Galor S, Benzie IFF. Herbal medicine: An introduction to its history, usage, regulation, current trends, and research needs. In: Benzie IFF, Wachtel-Galor S, eds. Herbal Medicine: Bio-molecular and Clinical Aspects. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; 2011.
198. Wang JG, Anderson RA, Graham GM, et al. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril 2007;88(1):240-3. [DOI:10.1016/j.fertnstert.2006.11.082]
199. Weinberg CR, Wilcox AJ, Baird DD. Reduced fecundability in women with prenatal exposure to cigarette smoking. Am J Epidemiol 1989;129(5):1072-78. [DOI:10.1093/oxfordjournals.aje.a115211]
200. Weiss RV, Clapauch R. Female infertility of endocrine origin. Arq Bras Endocrinol Metabol 2014;58(2):144-52. [DOI:10.1590/0004-2730000003021]
201. Wilding JPH. Endocrine testing in obesity. Eur J Endocrinol 2020;182(4):13-15. [DOI:10.1530/EJE-20-0099]
202. Wiweko B, Maidarti M, Priangga MD, et al. Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients. J Assist Reprod Genet 2014;31(10):1311-16. [DOI:10.1007/s10815-014-0300-6]
203. Wiweko B, Susanto CA. The effect of metformin and cinnamon on serum anti-mullerian hormone in women having PCOS: A Double-Blind, Randomized, Controlled Trial. J Hum Reprod Sci 2017;10(1):31-36.
204. World Health Organization (WHO). “Health Topics.” https://www.who.int/health-topics/infertility#tab=tab_1 (accessed October 26, 2022)
205. World Health Organization (WHO). “Traditional Medicine.” http://www.who.int/topics/traditional_medicine/en/(accessed July 29, 2021)
206. World Health Organization (WHO). International classification of diseases, 11th Revision (ICD-11) Geneva: WHO 2018.
207. World Health Organization (WHO). National policy on traditional medicine and regulation of herbal medicines. Geneva: 2005. Report of WHO global survey.
208. World Health Organization. Infecundity, infertility and childlessness in developing countries. de-mographic and health surveys (DHS) Comparative Reports No 9. 2004.
209. Xu H, Becker CM, Lui WT, et al. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 ex-pression and signaling in experimental endometriosis in vivo. Fertil Steril 2011;96(4):1021-28. [DOI:10.1016/j.fertnstert.2011.07.008]
210. Xu H, Lui WT, Chu CY, Ng PS, Wang CC, Rogers MS. Anti-angiogenic effects of green tea cate-chin on an experimental endometriosis mouse model. Hum Reprod 2009;24(3):608-18. [DOI:10.1093/humrep/den417]
211. Yang Q, Goto H, Hikiami H. “Effect of Toki-shakuyaku-san on microcirculation of bulbar conjuncti-va and hemorheological factors in patients with asymptomatic cerebral infarction. J Tradit Med 2004; 21: 170-3.
212. Zakeri S, Esmaeilzadeh S, Gorji N, Memariani Z, Moeini R, Bijani A. The effect of achillea millefoli-um l. on vulvovaginal candidiasis compared with clotrimazole: A randomized controlled trial. Com-plement Ther Med 2020;52. [DOI:10.1016/j.ctim.2020.102483]
213. Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fer-tility care. Hum Reprod 2017; 32(9):1786-1801. [DOI:10.1093/humrep/dex234]
214. Zhang GJ, Ji JY, Liu Q, Zhang LH, Gong GY, Jin ZX, Ren SZ. Collected edition of identification and assessment of common TCD. Heilongjiang Science and Technique Press, Harbin, China 1993; 301- 02.
215. Zhang JH, Xin HL, Xu YM, et al. Morinda officinalis How. A comprehensive review of traditional uses, phytochemistry and pharmacology. J Ethnopharmacol 2018;213:230-55. [DOI:10.1016/j.jep.2017.10.028]
216. Zhang RX, Li MX, Jia ZP. Rehmannia glutinosa: review of botany, chemistry and pharmacology. J Ethnopharmacol 2008; 117(2):199-214. [DOI:10.1016/j.jep.2008.02.018]
217. Zhao M, Wu SP. A review of the ethnobotany, phytochemistry and pharmacology of tree peony (Sect. Moutan). S AFR J BOT 2019; 124, 556-63. [DOI:10.1016/j.sajb.2019.05.018]
218. Zhao RH, Liu Y, Tan Y, et al. Chinese medicine improves postoperative quality of life in endome-triosis patients: a randomized controlled trial. Chin J Integr Med 2013;19(1):15-21. [DOI:10.1007/s11655-012-1196-6]
219. Zheng W, Cao L, Xu Z, Ma Y, Liang X. Anti-angiogenic alternative and complementary medicines for the treatment of endometriosis: A review of potential molecular mechanisms. Evid Based Com-plement Alternat Med 2018; 4128984. [DOI:10.1155/2018/4128984]
220. Zhou X, Li T, Fan S, et al. The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis. Mycoses 2016;59(7):419-28. [DOI:10.1111/myc.12485]
221. Zhu S, Liu D, Huang W, et al. Post-laparoscopic oral contraceptive combined with Chinese herbal mixture in treatment of infertility and pain associated with minimal or mild endometriosis: a random-ized controlled trial. BMC Complement Altern Med 2014;14:222. [DOI:10.1186/1472-6882-14-222]
222. Zick SM, Djuric Z, Ruffin MT, et al. Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008;17(8):1930-36. [DOI:10.1158/1055-9965.EPI-07-2934]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.